|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 33.22 USD | +0.79% |
|
+1.10% | +5.33% |
Company Valuation: MBX Biosciences, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| Capitalization 1 | 615.9 | 1,416 | 1,578 | - | - |
| Change | - | 129.95% | 11.44% | - | - |
| Enterprise Value (EV) 1 | 615.9 | 1,043 | 1,463 | 1,425 | 1,482 |
| Change | - | 69.27% | 40.35% | -2.58% | 3.99% |
| P/E ratio | -3.17x | -13.3x | -11.5x | -8.98x | -8.36x |
| PBR | 2.39x | 3.84x | 1.84x | 2.7x | 3.85x |
| PEG | 0x | 0.2x | -0.5x | -0.3x | -1.12x |
| Capitalization / Revenue | - | - | - | - | 67x |
| EV / Revenue | - | - | - | - | 62.9x |
| EV / EBITDA | -9.06x | -10.7x | -9.76x | -5.22x | -4.68x |
| EV / EBIT | -9.03x | -10.6x | -9.92x | -6.68x | -5.93x |
| EV / FCF | -11.1x | -12.7x | -11.8x | -8.61x | -6.69x |
| FCF Yield | -9.02% | -7.85% | -8.44% | -11.6% | -14.9% |
| Dividend per Share 2 | - | - | - | - | - |
| Rate of return | - | - | - | - | - |
| EPS 2 | -5.82 | -2.38 | -2.886 | -3.699 | -3.975 |
| Distribution rate | - | - | - | - | - |
| Net sales 1 | - | - | - | - | 23.57 |
| EBITDA 1 | -67.95 | -97.81 | -149.8 | -273.3 | -316.9 |
| EBIT 1 | -68.19 | -98.06 | -147.5 | -213.5 | -250.1 |
| Net income 1 | -61.92 | -86.97 | -136.9 | -187.9 | -221.7 |
| Net Debt 1 | - | -373.7 | -115.2 | -152.9 | -95.95 |
| Reference price 2 | 18.43 | 31.54 | 33.22 | 33.22 | 33.22 |
| Nbr of stocks (in thousands) | 33,417 | 44,902 | 47,510 | - | - |
| Announcement Date | 3/17/25 | 3/12/26 | - | - | - |
1USD in Million2USD
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -11.42x | - | -9.68x | -.--% | 1.57B | |
| 32.52x | 5.67x | 17.57x | 1.01% | 47.73B | |
| 57.83x | 5.02x | 33.69x | -.--% | 35.48B | |
| -19.65x | 517.75x | -18x | -.--% | 30.23B | |
| 21.92x | 2.49x | 10.72x | -.--% | 29.9B | |
| 33.67x | 8.29x | 21.31x | 0.37% | 28.75B | |
| 48.72x | 8.71x | 26.25x | -.--% | 14.93B | |
| 30.3x | 4.92x | 22.38x | -.--% | 14.81B | |
| 23.4x | 2.04x | 8.92x | 1.08% | 14.42B | |
| Average | 24.14x | 69.36x | 12.57x | 0.27% | 24.2B | |
| Weighted average by Cap. | 28.14x | 76.97x | 14.97x | 0.34% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- MBX Stock
- Valuation MBX Biosciences, Inc.
Select your edition
All financial news and data tailored to specific country editions
